4Bio Capital UK 

4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector. 4BIO’s objective is to invest in, support, and grow early stage companies developing treatments in areas of high unmet medical need, with the ultimate goal of ensuring access to these potentially curative therapies for all patients. Specifically, it looks for viable, high-quality opportunities in cell and gene therapy, RNA-based therapy, targeted therapies, and the microbiome.

About us

The 4BIO team comprises leading advanced therapy scientists and experienced life science investors who have collectively published over 250 scientific articles in prestigious academic journals including Nature, The Lancet, Cell, and the New England Journal of Medicine. 4BIO has both an unrivalled network within the advanced therapy sector and a unique understanding of the criteria that define a successful investment opportunity in this space.

Highlights

• London based VC firm focused on advanced therapeutics offering investors undiluted access to fastest-growing field of medicine. 
• Strong interest in Cell & Gene Therapy, next-gen RNA therapies and the human microbiome. 
• 4Bio ICAV Advanced Therapies Long Equity Fund to build, support and grow advanced therapy companies to ensure sustainable, global access to therapies that have the potential to cure chronic disease We aim to leverage our teams unique expertise and in depth knowledge of advanced therapies to make informed investment decisions, that will create the leading companies of the future.
  

Website | https://www.4biocapital.com/

Schedule a 1:1 business networking meeting with 4Bio Capital